UK Markets close in 6 hrs 22 mins

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
219.60-2.71 (-1.22%)
At close: 04:00PM EST
220.28 +0.68 (+0.31%)
Pre-market: 04:32AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3468.55
52-week low 3214.88
50-day moving average 3238.71
200-day moving average 3291.78

Share statistics

Avg vol (3-month) 31.6M
Avg vol (10-day) 32.47M
Shares outstanding 5146.89M
Implied shares outstanding 6N/A
Float 8146.51M
% held by insiders 10.66%
% held by institutions 186.55%
Shares short (30 Dec 2021) 42.46M
Short ratio (30 Dec 2021) 41.41
Short % of float (30 Dec 2021) 41.89%
Short % of shares outstanding (30 Dec 2021) 41.68%
Shares short (prior month 29 Nov 2021) 42.39M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 13.92%
Operating margin (ttm)23.02%

Management effectiveness

Return on assets (ttm)6.55%
Return on equity (ttm)19.47%

Income statement

Revenue (ttm)11.1B
Revenue per share (ttm)73.62
Quarterly revenue growth (yoy)-17.70%
Gross profit (ttm)11.64B
EBITDA 3.02B
Net income avi to common (ttm)1.55B
Diluted EPS (ttm)10.22
Quarterly earnings growth (yoy)-53.10%

Balance sheet

Total cash (mrq)2.96B
Total cash per share (mrq)20.12
Total debt (mrq)7.62B
Total debt/equity (mrq)70.02
Current ratio (mrq)1.70
Book value per share (mrq)71.00

Cash flow statement

Operating cash flow (ttm)2.43B
Levered free cash flow (ttm)1.3B